Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Non-Current Assets: 2023-2024

Historic Non-Current Assets for CG Oncology (CGON) over the last 2 years, with Dec 2024 value amounting to $587,000.

  • CG Oncology's Non-Current Assets rose 8627.11% to $34.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $34.1 million, marking a year-over-year increase of 8627.11%. This contributed to the annual value of $587,000 for FY2024, which is 88.66% down from last year.
  • As of FY2024, CG Oncology's Non-Current Assets stood at $587,000, which was down 88.66% from $5.2 million recorded in FY2023.
  • Over the past 5 years, CG Oncology's Non-Current Assets peaked at $5.2 million during FY2023, and registered a low of $587,000 during FY2024.
  • For the 2-year period, CG Oncology's Non-Current Assets averaged around $2.9 million, with its median value being $2.9 million (2023).
  • Data for CG Oncology's Non-Current Assets shows a maximum YoY plummeted of 88.66% (in 2024) over the last 5 years.
  • Over the past 2 years, CG Oncology's Non-Current Assets (Yearly) stood at $5.2 million in 2023, then slumped by 88.66% to $587,000 in 2024.